New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
D015250:Aclarubicin; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D006224:Cricetinae; D003630:Daunorubicin / Q000627:therapeutic use; D004285:Dogs; D004317:Doxorubicin / Q000627:therapeutic use; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009279:Naphthacenes / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011817:Rabbits; D051381:Rats
D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D015250:Aclarubicin; D004317:Doxorubicin; D003630:Daunorubicin